Beranda › Sklerosis Multipel › Maryland
Uji klinis Sklerosis Multipel di Maryland
17 studi untuk Sklerosis Multipel mencari peserta di lokasi di Maryland.
Kota di Maryland
Teks studi resmi (Bahasa Inggris)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Baltimore
- TG Therapeutics Investigational Trial Site, Glen Burnie
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Month – 99 Years · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00794352Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT00001248Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 2
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT02784210Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Baltimore Veterans Affairs Medical Center- Site Number : 8400163, Baltimore
Menerima pesertaFase 3
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Sunstone Therapies, PC, Rockville
- Sheppard Pratt, Towson
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 2 hingga 120 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT01730131Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1/2
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT03109288A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Mid Atlantic Epilepsy and Sleep Ctr, Bethesda
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07225504Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- Johns Hopkins University, Baltimore
Menerima pesertaFase 2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT07497399Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
- Johns Hopkins University, Baltimore
Menerima pesertaFase 2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT06170970Pathological Basis of MRI Signal Changes in Multiple Sclerosis
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT02659956Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
- National Institutes of Health Clinical Center, Bethesda
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT05849467Genes and Environment in Multiple Sclerosis
- National Institute of Neurological Disorders and Stroke, Bethesda
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT01353547Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis
- Johns Hopkins University, Baltimore
Menerima pesertaFase 4
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07389590A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
- Evidera INC., Bethesda
- Evidera, Bethesda
Menerima pesertaStudi observasional
Semua usia · Wanita · Diperbarui 20 Nov 2025 · NCT05170126Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.